Replies to post #557230 on NorthWest Biotherapeutics Inc (NWBO)

[pgsd]

Agreed, also good to hear Dr Toms make it clear that it was the FDA that mandated the crossover option.

[flipper44]

If you take the new STA 2022 protocol NWBO started under with NICE on December 23, 2022. If you count that as week “0”, week 8, when an evidence submission is due under the general STA timeline, would be February 17, 2023. (Kinda funny how they exited the 2018 STA and entered the 2022 STA without people noticing because of the kerfuffle.)

Kinda matches up with the scanning countdown, plus a cushion to add the latest (MIA) prerequisite material? Maybe simultaneous submissions? MAA and NICE?

Also matches up with NICE saying they expect the next contact from NWBO early in 2023.

https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/technology-appraisal-guidance/process/sta-timeline